Ilaria Grazia Zizzari Selected Research

Carbohydrates

1/2015

MGL Receptor and Immunity: When the Ligand Can Make the Difference.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilaria Grazia Zizzari Research Topics

Disease

20	Neoplasms (Cancer) 06/2022 - 01/2011
4	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2011
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2018
4	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 10/2020
2	Ascites 01/2017 - 01/2011
1	Glioblastoma (Glioblastoma Multiforme) 06/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	medullary Thyroid cancer 01/2021
1	Carcinogenesis 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Papilloma (Papillomatosis) 01/2021
1	Ovarian Epithelial Carcinoma 10/2020
1	Inflammation (Inflammations) 09/2020
1	Uveal melanoma 07/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Vulvar Neoplasms (Vulvar Cancer) 10/2016
1	Hypersensitivity (Allergy) 01/2015
1	Infections 01/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2011

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2016
4	Proteins (Proteins, Gene)FDA Link 07/2021 - 12/2011
4	NivolumabIBA 01/2021 - 01/2019
4	AntigensIBA 01/2017 - 01/2011
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	Tyrosine Kinase InhibitorsIBA 01/2021 - 01/2018
3	Monoclonal AntibodiesIBA 01/2021 - 01/2011
2	LectinsIBA 06/2022 - 10/2020
2	Polysaccharides (Glycans)IBA 06/2022 - 10/2020
2	Glycoproteins (Glycoprotein)IBA 10/2020 - 01/2017
2	Galactose (Galactopyranose)FDA LinkGeneric 10/2020 - 01/2015
2	C-Type Lectins (C-Type Lectin)IBA 10/2020 - 01/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2020 - 01/2018
2	CytokinesIBA 09/2020 - 12/2016
2	AntibodiesIBA 01/2020 - 01/2011
2	Peptides (Polypeptides)IBA 04/2016 - 12/2011
1	LigandsIBA 06/2022
1	Cyclin-Dependent Kinase 4IBA 05/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2021
1	PlatinumIBA 01/2021
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	cabozantinibIBA 01/2021
1	pembrolizumabIBA 01/2021
1	AutoantibodiesIBA 12/2020
1	Immunoglobulin M (IgM)IBA 12/2020
1	SugarsIBA 10/2020
1	Vicia lectinsIBA 10/2020
1	ChemokinesIBA 09/2020
1	Bevacizumab (Avastin)FDA Link 03/2019
1	Aldehyde Dehydrogenase 1 FamilyIBA 01/2018
1	Biological ProductsIBA 01/2018
1	Cancer VaccinesIBA 01/2018
1	AldehydesIBA 01/2018
1	VaccinesIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 12/2016
1	Interleukin-2 (IL2)IBA 12/2016
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2016
1	AC133 AntigenIBA 10/2016
1	Adenosine Triphosphate (ATP)IBA 10/2016
1	ParaffinIBA 10/2016
1	Monatide (IMS 3015)IBA 04/2016
1	Carcinoembryonic AntigenIBA 04/2016
1	CarbohydratesIBA 01/2015
1	AutoantigensIBA 01/2015
1	EpitopesIBA 12/2011
1	Immunoglobulin G (IgG)IBA 12/2011
1	Complementary DNA (cDNA)IBA 12/2011
1	oregovomabIBA 01/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2011
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2011
1	Epithelial Cell Adhesion MoleculeIBA 01/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011
1	Trastuzumab (Herceptin)FDA Link 01/2011
1	farletuzumabIBA 01/2011
1	human ERBB2 proteinIBA 01/2011

Therapy/Procedure

11	Immunotherapy 05/2022 - 12/2011
10	Therapeutics 05/2022 - 01/2011
1	Immunomodulation 05/2022
1	Drug Therapy (Chemotherapy) 03/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018